TS 106 antibodies (against Human Thymidylate Synthase)

Company
Zymed Laboratories, Inc.
Use
Used as a research reagent to enhance the understanding of certain cancers that exhibit elevated expression of thymidylate synthase
Features
A critical target enzyme in cancer chemotherapy
NIH Contribution
Developed monoclonal antibodies for Human Thymidylate Synthase
HHS Institute/Agency
NCI
Inventor(s)
P. Johnston, C. Allegra, B. Chabner, C. Liang
Year
2002
Tech Cat
Research Reagent